Missouri jury rejects three women's Roundup cancer claims against Bayer's Monsanto

A Missouri jury ruled in favor of Bayer's Monsanto business in a trial over claims that its Roundup weedkiller caused cancer, rejecting allegations of design defect, fraud and negligence brought by three plaintiffs. It was Bayer's first US trial victory since a favorable Supreme Court ruling in June; Bayer said it will continue defending its glyphosate-based products while pursuing a $7.25 billion settlement strategy.

Detected & updated continuously · Source: Nebula

Story subjects

Bayer AGSt. Louis

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula